Veraxa Biotech CEO Christoph Antz reports purchase of 5,000 shares for $7,650
VRXA•CEO reports insider share purchase
- Veraxa Biotech CEO and director Christoph Rudiger Antz reported a purchase of 5,000 ordinary shares.
- The shares were bought at $1.53 each.
- His direct holding rose to 5,000 ordinary shares.




